Sections
1. Investment Snapshot
2. Price Chart
3. Valuation & Price Target
4. Business & Product Moat
5. Market & Macro
Discussion
Investment Snapshot
Price Chart
Valuation & Price Target
Business & Product Moat
Market & Macro
Discussion
Propanc Biopharma, Inc.
Investment Snapshot
Symbol
PPCB
IPO Date (Actual)
2025-08-15
Offer Range
$4.00
Shares Offered
1.0M
Total Shares Post-IPO
13.6M
Market Cap
—
Target Price
$00.00Implied Upside vs Midpoint
$00.00Use of Proceeds
—
Price Chart
Historic Price Chart - PPCB
Valuation & Price Target
████████████████████
Business & Product Moat
████████████████████
Competitor Set
████████████████████Market & Macro
Sector context: Pharmaceutical Preparations
Same-industry IPOs from the last 365 days (as of 2026-06-04). Returns from IPO open price.
Median IPO open → current
-10.8%
win 25% · n=4Median first month
-17.0%
win 25% · n=4| Company | IPO Date | Open → Current | First Month |
|---|---|---|---|
AVLN Avalyn Pharma Inc. | 2026-04-30 | +11.0% | +11.0% |
KLRA Kailera Therapeutics, Inc. | 2026-04-17 | -18.4% | -19.5% |
GENB Generate Biomedicines, Inc. | 2026-02-27 | -3.1% | -14.4% |
CURX Curanex Pharmaceuticals Inc | 2025-08-26 | -92.4% | -83.5% |